Article
Repeated intermittent administration of (R)-ketamine during juvenile and adolescent stages prevents schizophrenia-relevant phenotypes in adult offspring after maternal immune activation: a role of TrkB signaling.
European archives of psychiatry and clinical neuroscience - 1 Jun 2022
Tan Yunfei, Fujita Yuko, Pu Yaoyu, Chang Lijia, Qu Youge, Wang Xinming, Hashimoto Kenji
Abstract excerpt
Maternal immune activation (MIA) plays a role in the etiology of schizophrenia. MIA by prenatal exposure of polyinosinic:polycytidylic acid [poly(I:C)] in rodents caused behavioral and neurobiological changes relevant to schizophrenia in adult offspring. We investigated whether the novel antidepressant (R)-ketamine could prevent the development of psychosis-like phenotypes in adult offspring after MIA. We...
Topics
Join the communities discussing this publication.
